Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Carboplatin-Paclitaxel in Advanced or Recurrent Endometrial Cancer
NCT01770171Phase 2Unknown
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Apr 2012
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in endometrial cancer (EC), sponsored by Università Cattolica del Sacro Cuore. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01770171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770171.